BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 30604628)

  • 1. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.
    Wang S; Liu M; Li X; Zhang J; Wang F; Zhang C; Roden A; Ryu JH; Warrington KJ; Sun J; Matteson EL; Tschumperlin DJ; Vassallo R
    FASEB J; 2022 Jun; 36(6):e22336. PubMed ID: 35522243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis.
    Samarpita S; Ganesan R; Rasool M
    Toxicol Appl Pharmacol; 2020 Mar; 391():114917. PubMed ID: 32044269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood.
    Zrioual S; Toh ML; Tournadre A; Zhou Y; Cazalis MA; Pachot A; Miossec V; Miossec P
    J Immunol; 2008 Jan; 180(1):655-63. PubMed ID: 18097068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 17 regulates SHP-2 and IL-17RA/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis.
    Ganesan R; Rasool M
    Mol Immunol; 2017 Nov; 91():134-144. PubMed ID: 28898718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A/IL-17RA interaction blockade sensitizes synovial macrophages to efferocytosis and PD-L1 signaling via rewiring STAT-3/ADAM17/MERTK axis in rheumatoid arthritis animal model.
    Samarpita S; Srivastava S; Srikanth M; Miriam Jose A; Rithvik A; Rasool M
    Int Immunopharmacol; 2024 Jul; 136():112343. PubMed ID: 38810305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3).
    Wu C; Lin H; Zhang X
    Int Immunopharmacol; 2019 Sep; 74():105700. PubMed ID: 31228816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
    Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
    Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.
    Samara KD; Trachalaki A; Tsitoura E; Koutsopoulos AV; Lagoudaki ED; Lasithiotaki I; Margaritopoulos G; Pantelidis P; Bibaki E; Siafakas NM; Tzanakis N; Wells AU; Antoniou KM
    Respir Res; 2017 Dec; 18(1):218. PubMed ID: 29287593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.
    Zheng W; Hu X; Zou M; Hu N; Song W; Wang R; Liu Y; Hou Q; Liu Y; Chen X; Cheng Z
    Inflammation; 2023 Feb; 46(1):285-296. PubMed ID: 36044099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
    van Baarsen LG; Lebre MC; van der Coelen D; Aarrass S; Tang MW; Ramwadhdoebe TH; Gerlag DM; Tak PP
    Arthritis Res Ther; 2014 Aug; 16(4):426. PubMed ID: 25146432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Wnt7b protein in rheumatoid arthritis: Detection of interstitial lung disease.
    Rabie M; El-Hady HIA; Ibrahim DA; Hassan TH; Abdelhady EI
    Immunobiology; 2023 Jul; 228(4):152397. PubMed ID: 37290224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
    Diesler R; Cottin V
    Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
    Jeong E; Hong H; Lee YA; Kim KS
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Crestani B; Dieudé P
    Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
    Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
    Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis.
    Zhu Y; Zheng X; Wang C; Sun X; Sun H; Ma T; Li Y; Liu K; Chen L; Ma X
    Bioorg Med Chem; 2020 Jan; 28(2):115254. PubMed ID: 31866272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
    Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
    Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.